Literature DB >> 10896783

Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.

S L Hsu1, J W Hsu, M C Liu, L Y Chen, C D Chang.   

Abstract

Retinoids are promising agents for the prevention and treatment of several human malignancies including lung cancer. In this study, the effect of retinoic acid (RA) on cell growth and the mechanism of growth modulation were examined in human lung squamous carcinoma CH27 cells. Here we report that RA mediated the dose- and time-dependent growth arrest in G1 phase, accompanied by the up-regulation of p27(Kip1) and the down-regulation of the cyclin-dependent kinase 3 (Cdk3) and p21(CIP1/Waf1) proteins. Furthermore, RA-induced growth arrest of CH27 cells was also associated with increased retinoic acid receptor beta (RARbeta) and reduced c-Myc expression. However, RA had no effect on the levels of cyclins A, D1, D3, E, or H, or on Cdk2, Cdk4, Cdk5, CDk6, Cdk7, p16(Ink4A), p15(Ink4B), p53, or pRb proteins in CH27 cells. Evaluation of the kinase activity of cyclin-Cdk complexes showed that RA increases p27(Kip1) expression in CH27 cells leading to markedly reduced cyclin A/Cdk2 kinase activity and slightly reduced cyclin E/Cdk2 kinase activity, with no effect on cyclin D/Cdk4 and cyclin D/Cdk6 activities. Moreover, coincident with the decrease in kinase activity was a drastic increase in cyclin A-bound p27(Kip1). These results suggest that increases in the levels of p27(Kip1) and its binding to cyclin A, as well as reduction of Cdk3 protein expression, are strong candidates for the cell cycle regulator that prevents the entry into the S phase in RA-treated CH27 cells, with prolongation of G1 phase and inhibition of DNA synthesis. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10896783     DOI: 10.1006/excr.2000.4933

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  13 in total

Review 1.  Role of retinoid signaling in the regulation of spermatogenesis.

Authors:  S S W Chung; D J Wolgemuth
Journal:  Cytogenet Genome Res       Date:  2004       Impact factor: 1.636

Review 2.  Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.

Authors:  Jiao Zhang; Yan-Hua Chen; Qun Lu
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

3.  Retinoids arrest breast cancer cell proliferation: retinoic acid selectively reduces the duration of receptor tyrosine kinase signaling.

Authors:  Ann P Tighe; David A Talmage
Journal:  Exp Cell Res       Date:  2004-12-10       Impact factor: 3.905

Review 4.  Retinoid mechanisms and cyclins.

Authors:  J O Boyle
Journal:  Curr Oncol Rep       Date:  2001-07       Impact factor: 5.075

5.  Retinoic acid receptor alpha is required for synchronization of spermatogenic cycles and its absence results in progressive breakdown of the spermatogenic process.

Authors:  Sanny S W Chung; Wengkong Sung; Xiangyuan Wang; Debra J Wolgemuth
Journal:  Dev Dyn       Date:  2004-08       Impact factor: 3.780

6.  Retinoic acid inhibits the growth of bone marrow mesenchymal stem cells and induces p27Kip1 and p16INK4A up-regulation.

Authors:  Adriana Oliva; Adriana Borriello; Stefania Zeppetelli; Angelo Di Feo; Pilade Cortellazzi; Vega Ventriglia; Maria Criscuolo; Vincenzo Zappia; Fulvio Della Ragione
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

7.  Fbxl12 triggers G1 arrest by mediating degradation of calmodulin kinase I.

Authors:  Rama K Mallampalli; Leah Kaercher; Courtney Snavely; Roopa Pulijala; Bill B Chen; Tiffany Coon; Jing Zhao; Marianna Agassandian
Journal:  Cell Signal       Date:  2013-05-23       Impact factor: 4.315

8.  Retinoids augment the expression of podocyte proteins by glomerular parietal epithelial cells in experimental glomerular disease.

Authors:  Jiong Zhang; Jeffrey W Pippin; Michael R Vaughan; Ronald D Krofft; Yoshinori Taniguchi; Paola Romagnani; Peter J Nelson; Zhi-Hong Liu; Stuart J Shankland
Journal:  Nephron Exp Nephrol       Date:  2012-10-25

9.  Retinoic acid and cancer treatment.

Authors:  Mei-Chih Chen; Shih-Lan Hsu; Ho Lin; Tsung-Ying Yang
Journal:  Biomedicine (Taipei)       Date:  2014-11-28

10.  miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells.

Authors:  Eric R Lechman; Bernhard Gentner; Stanley W K Ng; Erwin M Schoof; Peter van Galen; James A Kennedy; Silvia Nucera; Fabio Ciceri; Kerstin B Kaufmann; Naoya Takayama; Stephanie M Dobson; Aaron Trotman-Grant; Gabriela Krivdova; Janneke Elzinga; Amanda Mitchell; Björn Nilsson; Karin G Hermans; Kolja Eppert; Rene Marke; Ruth Isserlin; Veronique Voisin; Gary D Bader; Peter W Zandstra; Todd R Golub; Benjamin L Ebert; Jun Lu; Mark Minden; Jean C Y Wang; Luigi Naldini; John E Dick
Journal:  Cancer Cell       Date:  2016-01-28       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.